spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal, the global name in temperature controlled packaging, will highlight the rise of reusable temperature controlled packaging as guest speakers at Clinical Trial Supply Europe, being held in Milan on March 13 – 14, 2019.

Alongside exhibiting its high-performing parcel shippers and innovative CoolPall™ Flex system at CTS Europe, Peli BioThermal will be leading roundtable discussions plus presenting the latest developments in reusable systems.

Sharing knowledge and expertise will be Paul Terry, Peli BioThermal’s Director of Sales EMEA, who will be hosting a presentation entitled Considerations when Implementing Reuseable Temperature Controlled Packaging.

During Peli BioThermal’s presentation and roundtable talks, the team will address key drivers for deploying reusable shippers alongside insight into the latest ownership options plus rental and leasing strategies available to the clinical trial sector and life sciences industries.

Paul Terry said: “CTS Europe is an important conference for the company as the clinical trial sector is an area of substantial growth for Peli BioThermal which supplies award-winning, high-performing products providing protection for the global transportation of clinical trials materials.

“As guest speakers at this event we look forward to sharing our extensive experience and knowledge alongside the latest industry insights, deveoplments and service solutions.”

Exhibiting at Stand 22 at CTS Europe, Peli BioThermal will showcase its services and temperature controlled shippers including ts award-winning Chronos™ Advance, Chronos™ Express and Crēdo™ Cube shippers, tailored to meet the demands of more complex, international clinical trial supply regulatory requirements.

Peli BioThermal will be sharing industry insight at the conference, which brings together sector experts, leading service-providers and senior level decision makers from pharmaceutical and biotech companies, providing a platform for clinical supply professionals to discuss the latest industry issues and innovations.

Visit the Peli BioThermal exhibition at stand 22 at Clinical Trial Supply Europe or visit www.pelibiothermal.com  to learn more about the wide range of Peli BioThermal products and offerings.

Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.
phone +44 1525 243 770
web pelibiothermal.com/
email Celsius House, The Stanbridge Building, Stanbridge Road, Leighton Buzzard LU7 4QQ
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>


White Papers

Another Successful Visit Against the Odds

Medical Research Network (MRN) Limited

Our dedicated team of nurses, couriers and project managers deliver, come rain or shine. Making sure a Clinical Trial visit can go ahead in the home can be a complex process, and last month bad weather nearly stopped play on an important Home Trial Support visit. Thanks to the commitment and dedication from the entire team it went ahead against the odds.
More info >>

Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement